{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:39:06Z","timestamp":1794335946034,"version":"4.9.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"GSK","award":["209668"],"award-info":[{"award-number":["209668"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s12325-023-02531-z","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T12:01:37Z","timestamp":1688212897000},"page":"4101-4110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["B-Clear Phase\u00a02b Study Design: Establishing the Efficacy and Safety of Bepirovirsen in Patients with Chronic Hepatitis\u00a0B Virus Infection"],"prefix":"10.1007","volume":"40","author":[{"given":"Jennifer","family":"Cremer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Elston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Paff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dickens","family":"Theodore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,1]]},"reference":[{"issue":"1","key":"2531_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12985-021-01589-x","volume":"18","author":"A Song","year":"2021","unstructured":"Song A, Lin X, Chen X. Functional cure for chronic hepatitis\u00a0B: accessibility, durability, and prognosis. Virol J. 2021;18(1):114.","journal-title":"Virol J"},{"issue":"9959","key":"2531_CR2","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Trepo","year":"2014","unstructured":"Trepo C, Chan HL, Lok A. Hepatitis\u00a0B virus infection. Lancet. 2014;384(9959):2053\u201363.","journal-title":"Lancet"},{"key":"2531_CR3","doi-asserted-by":"publisher","first-page":"18035","DOI":"10.1038\/nrdp.2018.35","volume":"4","author":"MF Yuen","year":"2018","unstructured":"Yuen MF, Chen DS, Dusheiko GM, et al. Hepatitis\u00a0B virus infection. Nat Rev Dis Primers. 2018;4:18035.","journal-title":"Nat Rev Dis Primers"},{"key":"2531_CR4","unstructured":"World Health Organization. Hepatitis\u00a0B - Key facts 2021 https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Accessed 6 June 2023."},{"issue":"2","key":"2531_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis\u00a0B virus infection. J Hepatol. 2017;67(2):370\u201398.","journal-title":"J Hepatol"},{"issue":"1","key":"2531_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis\u00a0B: a 2015 update. Hepatol Int. 2016;10(1):1\u201398.","journal-title":"Hepatol Int"},{"issue":"1","key":"2531_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/hep.28156","volume":"63","author":"NA Terrault","year":"2016","unstructured":"Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis\u00a0B. Hepatology. 2016;63(1):261\u201383.","journal-title":"Hepatology"},{"issue":"4","key":"2531_CR8","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis\u00a0B: AASLD 2018 hepatitis\u00a0B guidance. Hepatology. 2018;67(4):1560\u201399.","journal-title":"Hepatology"},{"key":"2531_CR9","doi-asserted-by":"crossref","unstructured":"Cornberg M, Lok AS, Terrault NA, Zoulim F, EASL-AASLD HBV Treatment Endpoints Conference Faculty. Guidance for design and endpoints of clinical trials in chronic hepatitis\u00a0B\u2014Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference. J Hepatol. 2020; 72(3):539\u201357.","DOI":"10.1016\/j.jhep.2019.11.003"},{"issue":"3","key":"2531_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/hep4.1480","volume":"4","author":"A Do","year":"2020","unstructured":"Do A, Reau NS. Chronic viral hepatitis: current management and future directions. Hepatol Commun. 2020;4(3):329\u201341.","journal-title":"Hepatol Commun"},{"issue":"1","key":"2531_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/hep4.1476","volume":"4","author":"A Loglio","year":"2020","unstructured":"Loglio A, Lampertico P. How durable is functional cure (hepatitis\u00a0B surface antigen loss) in patients with chronic hepatitis\u00a0B treated with current antivirals? Hepatol Commun. 2020;4(1):5\u20137.","journal-title":"Hepatol Commun"},{"issue":"17","key":"2531_CR12","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1001\/jama.2018.3795","volume":"319","author":"LSY Tang","year":"2018","unstructured":"Tang LSY, Covert E, Wilson E, Kottilil S. Chronic hepatitis\u00a0B infection: a review. JAMA. 2018;319(17):1802\u201313.","journal-title":"JAMA"},{"issue":"3","key":"2531_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1053\/j.gastro.2018.10.027","volume":"156","author":"YH Yeo","year":"2019","unstructured":"Yeo YH, Ho HJ, Yang HI, et al. Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: a systematic review and meta-analysis. Gastroenterology. 2019;156(3):635-46.e9.","journal-title":"Gastroenterology"},{"issue":"3","key":"2531_CR14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cgh.2019.08.033","volume":"18","author":"TC Yip","year":"2020","unstructured":"Yip TC, Lok AS. How do we determine whether a functional cure for HBV infection has been achieved? Clin Gastroenterol Hepatol. 2020;18(3):548\u201350.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"2531_CR15","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/s41591-021-01513-4","volume":"27","author":"MF Yuen","year":"2021","unstructured":"Yuen MF, Heo J, Jang JW, et al. Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis\u00a0B: a phase\u00a02 randomized controlled trial. Nat Med. 2021;27(10):1725\u201334.","journal-title":"Nat Med"},{"issue":"21","key":"2531_CR16","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1056\/NEJMoa2210027","volume":"387","author":"M-F Yuen","year":"2022","unstructured":"Yuen M-F, Lim S-G, Plesniak R, et al. Efficacy and safety of bepirovirsen in chronic hepatitis\u00a0B infection. N Engl J Med. 2022;387(21):1957\u201368.","journal-title":"N Engl J Med"},{"issue":"1","key":"2531_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/0192623314551840","volume":"43","author":"KS Frazier","year":"2015","unstructured":"Frazier KS. Antisense oligonucleotide therapies: the promise and the challenges from a toxicologic pathologist\u2019s perspective. Toxicol Pathol. 2015;43(1):78\u201389.","journal-title":"Toxicol Pathol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02531-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02531-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02531-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T11:18:14Z","timestamp":1692098294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02531-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2531"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02531-z","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,1]]},"assertion":[{"value":"31 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}